These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8636540)

  • 61. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.
    Eur Heart J; 1995 Dec; 16(12):1825-32. PubMed ID: 8682014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Non arrhythmogenic sudden death as complication of coronary heart disease].
    Zilcher H; Glogar D
    Acta Med Austriaca; 1979; 6(2):59-66. PubMed ID: 42254
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).
    Rodriguez A; Mele E; Peyregne E; Bullon F; Perez-Baliño N; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1996 Apr; 27(5):1178-84. PubMed ID: 8609339
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
    Dargie HJ; Ford I; Fox KM
    Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years.
    Talley JD; Weintraub WS; Roubin GS; Douglas JS; Anderson HV; Jones EL; Morris DC; Liberman HA; Craver JM; Guyton RA
    Circulation; 1990 Oct; 82(4):1203-13. PubMed ID: 2401061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.
    Ruygrok PN; de Jaegere PT; van Domburg RT; van den Brand MJ; Serruys PW; de Feyter PJ
    J Am Coll Cardiol; 1996 Jun; 27(7):1669-77. PubMed ID: 8636552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of exercise test parameters to predict presence and duration of ambulatory ischemia in patients with coronary artery disease.
    Paul SD; Orav EJ; Gleason RE; Nesto RW
    Am J Cardiol; 1994 Nov; 74(10):991-6. PubMed ID: 7977060
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thrombolytic therapy in refractory unstable angina: the role of Holter monitoring.
    Brunelli C; Spallarossa P; Ghigliotti G; Lantieri P; Iannetti M; Caponnetto S
    Clin Cardiol; 1991 Apr; 14(4):297-304. PubMed ID: 1674454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rationale and design of J-ACCESS 4: prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease.
    Nanasato M; Nakajima K; Fujita H; Zen K; Kohsaka S; Hashimoto A; Moroi M; Fukuzawa S; Chikamori T; Nishimura S; Yamashina A; Kusuoka H; Hirayama A; Nishimura T
    J Cardiol; 2014 Feb; 63(2):159-64. PubMed ID: 24012330
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Silent myocardial ischemia: therapeutic implications.
    Resnekov L
    Am J Med; 1985 Sep; 79(3A):30-4. PubMed ID: 2864855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA
    Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance.
    Pfisterer M; Rickenbacher P; Kiowski W; Müller-Brand J; Burkart F
    J Am Coll Cardiol; 1993 Nov; 22(5):1446-54. PubMed ID: 8227804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
    Bertrand ME; Ferrari R; Remme WJ; Simoons ML; Fox KM
    Am Heart J; 2015 Dec; 170(6):1092-8. PubMed ID: 26678630
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?
    Poldermans D; Bax JJ; Schouten O; Neskovic AN; Paelinck B; Rocci G; van Dortmont L; Durazzo AE; van de Ven LL; van Sambeek MR; Kertai MD; Boersma E;
    J Am Coll Cardiol; 2006 Sep; 48(5):964-9. PubMed ID: 16949487
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.